GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000078561.3 | early B cell factor 1 |
Ebf1
|
ENSMUSG00000057098.8 | early B cell factor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ebf1 | mm10_v2_chr11_+_44617310_44617336 | 0.78 | 2.5e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_84980458 | 15.60 |
ENSMUST00000028467.5
|
Prg2
|
proteoglycan 2, bone marrow |
chrX_-_7967817 | 10.46 |
ENSMUST00000033502.7
|
Gata1
|
GATA binding protein 1 |
chr17_+_48359891 | 10.41 |
ENSMUST00000024792.6
|
Treml1
|
triggering receptor expressed on myeloid cells-like 1 |
chr16_-_16863975 | 9.73 |
ENSMUST00000100136.3
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr11_+_117797660 | 9.41 |
ENSMUST00000106331.1
|
6030468B19Rik
|
RIKEN cDNA 6030468B19 gene |
chr9_-_109849440 | 9.21 |
ENSMUST00000112022.2
|
Camp
|
cathelicidin antimicrobial peptide |
chr8_-_122460666 | 8.83 |
ENSMUST00000006762.5
|
Snai3
|
snail homolog 3 (Drosophila) |
chr2_+_131186942 | 8.70 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
Cdc25b
|
cell division cycle 25B |
chr11_-_102365111 | 8.46 |
ENSMUST00000006749.9
|
Slc4a1
|
solute carrier family 4 (anion exchanger), member 1 |
chr19_+_7268296 | 8.35 |
ENSMUST00000066646.4
|
Rcor2
|
REST corepressor 2 |
chr16_-_16863817 | 7.58 |
ENSMUST00000124890.1
|
Igll1
|
immunoglobulin lambda-like polypeptide 1 |
chr6_+_86628174 | 7.20 |
ENSMUST00000043400.6
|
Asprv1
|
aspartic peptidase, retroviral-like 1 |
chr4_+_134864536 | 7.00 |
ENSMUST00000030627.7
|
Rhd
|
Rh blood group, D antigen |
chr16_+_36156801 | 6.69 |
ENSMUST00000079184.4
|
Stfa2l1
|
stefin A2 like 1 |
chr17_+_25298389 | 6.29 |
ENSMUST00000037453.2
|
Prss34
|
protease, serine, 34 |
chr1_-_88205674 | 5.82 |
ENSMUST00000119972.2
|
Dnajb3
|
DnaJ (Hsp40) homolog, subfamily B, member 3 |
chr15_+_80623499 | 5.75 |
ENSMUST00000043149.7
|
Grap2
|
GRB2-related adaptor protein 2 |
chr12_-_4874341 | 5.73 |
ENSMUST00000137337.1
ENSMUST00000045921.7 |
Mfsd2b
|
major facilitator superfamily domain containing 2B |
chr10_+_79879614 | 5.68 |
ENSMUST00000006679.8
|
Prtn3
|
proteinase 3 |
chr14_-_51057242 | 5.50 |
ENSMUST00000089798.2
|
Rnase12
|
ribonuclease, RNase A family, 12 (non-active) |
chr11_-_102101310 | 5.42 |
ENSMUST00000170554.2
ENSMUST00000017460.5 |
Ppy
|
pancreatic polypeptide |
chr6_+_86078070 | 5.39 |
ENSMUST00000032069.5
|
Add2
|
adducin 2 (beta) |
chr14_-_60086832 | 5.37 |
ENSMUST00000080368.5
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr8_-_111691002 | 5.28 |
ENSMUST00000034435.5
|
Ctrb1
|
chymotrypsinogen B1 |
chr7_+_19411086 | 5.16 |
ENSMUST00000003643.1
|
Ckm
|
creatine kinase, muscle |
chr16_+_17980565 | 5.09 |
ENSMUST00000075371.3
|
Vpreb2
|
pre-B lymphocyte gene 2 |
chr17_+_28769307 | 5.02 |
ENSMUST00000004986.6
|
Mapk13
|
mitogen-activated protein kinase 13 |
chr11_+_115877497 | 5.00 |
ENSMUST00000144032.1
|
Myo15b
|
myosin XVB |
chr7_+_24370255 | 4.91 |
ENSMUST00000171904.1
|
Kcnn4
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
chr8_+_71597648 | 4.91 |
ENSMUST00000143662.1
|
Fam129c
|
family with sequence similarity 129, member C |
chrX_+_136033367 | 4.88 |
ENSMUST00000057625.2
|
Arxes1
|
adipocyte-related X-chromosome expressed sequence 1 |
chr12_+_109452833 | 4.88 |
ENSMUST00000056110.8
|
Dlk1
|
delta-like 1 homolog (Drosophila) |
chr18_-_35649349 | 4.85 |
ENSMUST00000025211.4
|
Mzb1
|
marginal zone B and B1 cell-specific protein 1 |
chr16_-_96443595 | 4.70 |
ENSMUST00000113773.1
ENSMUST00000000161.7 |
Itgb2l
|
integrin beta 2-like |
chr14_-_20269162 | 4.70 |
ENSMUST00000024155.7
|
Kcnk16
|
potassium channel, subfamily K, member 16 |
chr6_-_116461024 | 4.61 |
ENSMUST00000164547.1
ENSMUST00000170186.1 |
Alox5
|
arachidonate 5-lipoxygenase |
chr11_+_95010277 | 4.55 |
ENSMUST00000124735.1
|
Samd14
|
sterile alpha motif domain containing 14 |
chr7_-_142679533 | 4.54 |
ENSMUST00000162317.1
ENSMUST00000125933.1 ENSMUST00000105931.1 ENSMUST00000105930.1 ENSMUST00000105933.1 ENSMUST00000105932.1 ENSMUST00000000220.2 |
Ins2
|
insulin II |
chr8_+_23139030 | 4.54 |
ENSMUST00000121075.1
|
Ank1
|
ankyrin 1, erythroid |
chr6_-_115762346 | 4.50 |
ENSMUST00000166254.1
ENSMUST00000170625.1 |
Tmem40
|
transmembrane protein 40 |
chr7_+_79660196 | 4.42 |
ENSMUST00000035977.7
|
Ticrr
|
TOPBP1-interacting checkpoint and replication regulator |
chr8_+_23139064 | 4.41 |
ENSMUST00000033947.8
|
Ank1
|
ankyrin 1, erythroid |
chrX_-_136215443 | 4.40 |
ENSMUST00000113120.1
ENSMUST00000113118.1 ENSMUST00000058125.8 |
Bex1
|
brain expressed gene 1 |
chr7_+_96211656 | 4.39 |
ENSMUST00000107165.1
|
Tenm4
|
teneurin transmembrane protein 4 |
chr11_+_115154139 | 4.37 |
ENSMUST00000021076.5
|
Rab37
|
RAB37, member of RAS oncogene family |
chr6_+_41354105 | 4.22 |
ENSMUST00000072103.5
|
Try10
|
trypsin 10 |
chr7_+_24777172 | 4.21 |
ENSMUST00000038069.7
|
Ceacam10
|
carcinoembryonic antigen-related cell adhesion molecule 10 |
chr6_-_69284319 | 4.17 |
ENSMUST00000103349.1
|
Igkv4-69
|
immunoglobulin kappa variable 4-69 |
chr5_-_134946917 | 4.17 |
ENSMUST00000051401.2
|
Cldn4
|
claudin 4 |
chr6_+_30639218 | 4.15 |
ENSMUST00000031806.9
|
Cpa1
|
carboxypeptidase A1, pancreatic |
chr2_+_173022360 | 4.12 |
ENSMUST00000173997.1
|
Rbm38
|
RNA binding motif protein 38 |
chrX_+_135993820 | 4.11 |
ENSMUST00000058119.7
|
Arxes2
|
adipocyte-related X-chromosome expressed sequence 2 |
chr17_+_48232755 | 4.11 |
ENSMUST00000113251.3
ENSMUST00000048782.6 |
Trem1
|
triggering receptor expressed on myeloid cells 1 |
chr2_-_28084877 | 4.11 |
ENSMUST00000028179.8
ENSMUST00000117486.1 ENSMUST00000135472.1 |
Fcnb
|
ficolin B |
chr9_+_65101453 | 4.07 |
ENSMUST00000077696.6
ENSMUST00000035499.4 ENSMUST00000166273.1 |
Igdcc4
|
immunoglobulin superfamily, DCC subclass, member 4 |
chr5_+_137288273 | 4.05 |
ENSMUST00000024099.4
ENSMUST00000085934.3 |
Ache
|
acetylcholinesterase |
chr6_+_34412334 | 4.03 |
ENSMUST00000007449.8
|
Akr1b7
|
aldo-keto reductase family 1, member B7 |
chr12_-_109068173 | 4.01 |
ENSMUST00000073156.7
|
Begain
|
brain-enriched guanylate kinase-associated |
chr14_-_70630149 | 3.97 |
ENSMUST00000022694.9
|
Dmtn
|
dematin actin binding protein |
chr1_+_135840857 | 3.90 |
ENSMUST00000179863.1
ENSMUST00000112086.2 ENSMUST00000112087.2 ENSMUST00000112085.2 ENSMUST00000178854.1 ENSMUST00000027671.5 |
Tnnt2
|
troponin T2, cardiac |
chr7_-_100855403 | 3.90 |
ENSMUST00000156855.1
|
Relt
|
RELT tumor necrosis factor receptor |
chr5_-_145469723 | 3.85 |
ENSMUST00000031633.4
|
Cyp3a16
|
cytochrome P450, family 3, subfamily a, polypeptide 16 |
chr10_+_75566257 | 3.81 |
ENSMUST00000129232.1
ENSMUST00000143792.1 |
Ggt1
|
gamma-glutamyltransferase 1 |
chrX_-_52613936 | 3.79 |
ENSMUST00000114857.1
|
Gpc3
|
glypican 3 |
chr11_+_78346666 | 3.77 |
ENSMUST00000100755.3
|
Unc119
|
unc-119 homolog (C. elegans) |
chr8_+_83955507 | 3.71 |
ENSMUST00000005607.8
|
Asf1b
|
ASF1 anti-silencing function 1 homolog B (S. cerevisiae) |
chr11_+_58917889 | 3.71 |
ENSMUST00000069941.6
|
Btnl10
|
butyrophilin-like 10 |
chr7_+_142442330 | 3.70 |
ENSMUST00000149529.1
|
Tnni2
|
troponin I, skeletal, fast 2 |
chr2_+_25372315 | 3.66 |
ENSMUST00000028329.6
ENSMUST00000114293.2 ENSMUST00000100323.2 |
Sapcd2
|
suppressor APC domain containing 2 |
chr10_+_79881023 | 3.64 |
ENSMUST00000166201.1
|
Prtn3
|
proteinase 3 |
chrX_+_136138996 | 3.62 |
ENSMUST00000116527.1
|
Bex4
|
brain expressed gene 4 |
chr6_-_41704339 | 3.60 |
ENSMUST00000031899.8
|
Kel
|
Kell blood group |
chr11_+_115899943 | 3.60 |
ENSMUST00000152171.1
|
Smim5
|
small integral membrane protein 5 |
chr13_-_53286052 | 3.59 |
ENSMUST00000021918.8
|
Ror2
|
receptor tyrosine kinase-like orphan receptor 2 |
chr10_-_128401218 | 3.59 |
ENSMUST00000042666.5
|
Slc39a5
|
solute carrier family 39 (metal ion transporter), member 5 |
chr15_-_55090422 | 3.58 |
ENSMUST00000110231.1
ENSMUST00000023059.6 |
Dscc1
|
defective in sister chromatid cohesion 1 homolog (S. cerevisiae) |
chr2_-_163918683 | 3.52 |
ENSMUST00000044734.2
|
Rims4
|
regulating synaptic membrane exocytosis 4 |
chr15_+_75156693 | 3.51 |
ENSMUST00000023246.3
|
Ly6g
|
lymphocyte antigen 6 complex, locus G |
chr19_+_52264323 | 3.51 |
ENSMUST00000039652.4
|
Ins1
|
insulin I |
chr3_+_108364882 | 3.49 |
ENSMUST00000090563.5
|
Mybphl
|
myosin binding protein H-like |
chr14_-_60087347 | 3.48 |
ENSMUST00000149414.1
|
Atp8a2
|
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
chr11_+_7197780 | 3.40 |
ENSMUST00000020704.7
|
Igfbp1
|
insulin-like growth factor binding protein 1 |
chr7_-_142661858 | 3.40 |
ENSMUST00000145896.2
|
Igf2
|
insulin-like growth factor 2 |
chr11_+_87793722 | 3.40 |
ENSMUST00000143021.2
|
Mpo
|
myeloperoxidase |
chr7_-_142699510 | 3.39 |
ENSMUST00000105934.1
|
Ins2
|
insulin II |
chr8_-_85365317 | 3.36 |
ENSMUST00000034133.7
|
Mylk3
|
myosin light chain kinase 3 |
chr11_-_87875524 | 3.36 |
ENSMUST00000049768.3
|
Epx
|
eosinophil peroxidase |
chr2_-_24763047 | 3.35 |
ENSMUST00000100348.3
ENSMUST00000041342.5 ENSMUST00000114447.1 ENSMUST00000102939.2 ENSMUST00000070864.7 |
Cacna1b
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
chr9_+_110857958 | 3.26 |
ENSMUST00000051097.1
|
Prss50
|
protease, serine, 50 |
chr2_+_130295148 | 3.23 |
ENSMUST00000110288.2
|
Ebf4
|
early B cell factor 4 |
chr19_-_10203880 | 3.21 |
ENSMUST00000142241.1
ENSMUST00000116542.2 ENSMUST00000025651.5 ENSMUST00000156291.1 |
Fen1
|
flap structure specific endonuclease 1 |
chr7_+_141061274 | 3.20 |
ENSMUST00000048002.5
|
B4galnt4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr11_-_116076986 | 3.19 |
ENSMUST00000153408.1
|
Unc13d
|
unc-13 homolog D (C. elegans) |
chr6_-_116461151 | 3.14 |
ENSMUST00000026795.6
|
Alox5
|
arachidonate 5-lipoxygenase |
chr7_+_100493337 | 3.14 |
ENSMUST00000126534.1
|
Ucp2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr11_+_115900125 | 3.14 |
ENSMUST00000142089.1
ENSMUST00000131566.1 |
Smim5
|
small integral membrane protein 5 |
chr10_-_79788924 | 3.14 |
ENSMUST00000020573.6
|
Prss57
|
protease, serine 57 |
chr17_+_36869567 | 3.13 |
ENSMUST00000060524.9
|
Trim10
|
tripartite motif-containing 10 |
chr16_+_32756336 | 3.13 |
ENSMUST00000135753.1
|
Muc4
|
mucin 4 |
chr10_+_20347788 | 3.12 |
ENSMUST00000169712.1
|
Mtfr2
|
mitochondrial fission regulator 2 |
chr8_-_85365341 | 3.12 |
ENSMUST00000121972.1
|
Mylk3
|
myosin light chain kinase 3 |
chr4_+_130308595 | 3.10 |
ENSMUST00000070532.7
|
Fabp3
|
fatty acid binding protein 3, muscle and heart |
chr17_+_34597852 | 3.09 |
ENSMUST00000174496.2
ENSMUST00000015596.3 ENSMUST00000173992.1 |
Ager
|
advanced glycosylation end product-specific receptor |
chr16_-_16869255 | 3.09 |
ENSMUST00000075017.4
|
Vpreb1
|
pre-B lymphocyte gene 1 |
chr4_+_115057683 | 3.06 |
ENSMUST00000161601.1
|
Tal1
|
T cell acute lymphocytic leukemia 1 |
chr7_-_45238794 | 3.06 |
ENSMUST00000098461.1
ENSMUST00000107797.1 |
Cd37
|
CD37 antigen |
chr11_-_97996171 | 3.03 |
ENSMUST00000042971.9
|
Arl5c
|
ADP-ribosylation factor-like 5C |
chr5_-_43981757 | 3.03 |
ENSMUST00000061299.7
|
Fgfbp1
|
fibroblast growth factor binding protein 1 |
chr10_+_75943020 | 3.02 |
ENSMUST00000121151.1
|
Vpreb3
|
pre-B lymphocyte gene 3 |
chr1_+_134182150 | 3.01 |
ENSMUST00000156873.1
|
Chi3l1
|
chitinase 3-like 1 |
chr10_-_85102487 | 3.01 |
ENSMUST00000059383.6
|
Fhl4
|
four and a half LIM domains 4 |
chr1_+_75400070 | 3.00 |
ENSMUST00000113589.1
|
Speg
|
SPEG complex locus |
chrX_-_52613913 | 2.99 |
ENSMUST00000069360.7
|
Gpc3
|
glypican 3 |
chr4_+_46039202 | 2.98 |
ENSMUST00000156200.1
|
Tmod1
|
tropomodulin 1 |
chr11_+_62575981 | 2.97 |
ENSMUST00000102643.1
|
Trpv2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr2_+_13573927 | 2.96 |
ENSMUST00000141365.1
ENSMUST00000028062.2 |
Vim
|
vimentin |
chr5_+_136967859 | 2.94 |
ENSMUST00000001790.5
|
Cldn15
|
claudin 15 |
chr13_-_113100971 | 2.92 |
ENSMUST00000023897.5
|
Gzma
|
granzyme A |
chr8_+_57455898 | 2.92 |
ENSMUST00000034023.3
|
Scrg1
|
scrapie responsive gene 1 |
chr1_-_128592284 | 2.90 |
ENSMUST00000052172.6
ENSMUST00000142893.1 |
Cxcr4
|
chemokine (C-X-C motif) receptor 4 |
chr2_+_128591205 | 2.89 |
ENSMUST00000155430.1
|
Gm355
|
predicted gene 355 |
chr11_-_46312220 | 2.87 |
ENSMUST00000129474.1
ENSMUST00000093166.4 ENSMUST00000165599.2 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr11_-_69617879 | 2.84 |
ENSMUST00000005334.2
|
Shbg
|
sex hormone binding globulin |
chr8_+_94179089 | 2.82 |
ENSMUST00000034215.6
|
Mt1
|
metallothionein 1 |
chr9_-_21963568 | 2.81 |
ENSMUST00000006397.5
|
Epor
|
erythropoietin receptor |
chr17_-_6782775 | 2.80 |
ENSMUST00000064234.6
|
Ezr
|
ezrin |
chr3_-_132950043 | 2.80 |
ENSMUST00000117164.1
ENSMUST00000093971.4 ENSMUST00000042729.9 ENSMUST00000042744.9 ENSMUST00000117811.1 |
Npnt
|
nephronectin |
chr4_+_155962292 | 2.79 |
ENSMUST00000024338.4
|
Fam132a
|
family with sequence similarity 132, member A |
chr2_+_91035613 | 2.76 |
ENSMUST00000111445.3
ENSMUST00000111446.3 ENSMUST00000050323.5 |
Rapsn
|
receptor-associated protein of the synapse |
chr3_+_10012548 | 2.76 |
ENSMUST00000029046.8
|
Fabp5
|
fatty acid binding protein 5, epidermal |
chr14_+_70457447 | 2.76 |
ENSMUST00000003561.3
|
Phyhip
|
phytanoyl-CoA hydroxylase interacting protein |
chr6_-_115758974 | 2.74 |
ENSMUST00000072933.6
|
Tmem40
|
transmembrane protein 40 |
chr7_-_44532064 | 2.73 |
ENSMUST00000098483.2
ENSMUST00000035323.4 |
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr11_-_72411695 | 2.73 |
ENSMUST00000108500.1
ENSMUST00000050226.6 |
Smtnl2
|
smoothelin-like 2 |
chr1_+_135799833 | 2.73 |
ENSMUST00000148201.1
|
Tnni1
|
troponin I, skeletal, slow 1 |
chr6_+_71707561 | 2.69 |
ENSMUST00000121469.1
|
Reep1
|
receptor accessory protein 1 |
chr17_-_7352696 | 2.68 |
ENSMUST00000115747.1
|
Ttll2
|
tubulin tyrosine ligase-like family, member 2 |
chr4_-_127330799 | 2.68 |
ENSMUST00000046532.3
|
Gjb3
|
gap junction protein, beta 3 |
chr1_+_134182404 | 2.68 |
ENSMUST00000153856.1
ENSMUST00000082060.3 ENSMUST00000133701.1 ENSMUST00000132873.1 |
Chi3l1
|
chitinase 3-like 1 |
chrX_-_162964557 | 2.68 |
ENSMUST00000038769.2
|
S100g
|
S100 calcium binding protein G |
chr13_+_45507438 | 2.66 |
ENSMUST00000000260.6
|
Gmpr
|
guanosine monophosphate reductase |
chr17_+_5799491 | 2.65 |
ENSMUST00000181484.1
|
3300005D01Rik
|
RIKEN cDNA 3300005D01 gene |
chr17_-_26199008 | 2.65 |
ENSMUST00000142410.1
ENSMUST00000120333.1 ENSMUST00000039113.7 |
Pdia2
|
protein disulfide isomerase associated 2 |
chr7_+_143005638 | 2.65 |
ENSMUST00000075172.5
ENSMUST00000105923.1 |
Tspan32
|
tetraspanin 32 |
chr1_-_90153396 | 2.63 |
ENSMUST00000113094.2
|
Iqca
|
IQ motif containing with AAA domain |
chr16_-_18621366 | 2.62 |
ENSMUST00000051160.2
|
Gp1bb
|
glycoprotein Ib, beta polypeptide |
chr4_+_44300876 | 2.62 |
ENSMUST00000045607.5
|
Melk
|
maternal embryonic leucine zipper kinase |
chr2_+_79255500 | 2.61 |
ENSMUST00000099972.4
|
Itga4
|
integrin alpha 4 |
chr4_-_41048124 | 2.60 |
ENSMUST00000030136.6
|
Aqp7
|
aquaporin 7 |
chr4_+_49059256 | 2.59 |
ENSMUST00000076670.2
|
E130309F12Rik
|
RIKEN cDNA E130309F12 gene |
chr15_-_89425856 | 2.59 |
ENSMUST00000109313.2
|
Cpt1b
|
carnitine palmitoyltransferase 1b, muscle |
chr7_+_143005677 | 2.57 |
ENSMUST00000082008.5
ENSMUST00000105925.1 ENSMUST00000105924.1 |
Tspan32
|
tetraspanin 32 |
chr7_-_25615874 | 2.55 |
ENSMUST00000098663.1
|
Gm7092
|
predicted gene 7092 |
chr11_-_69900949 | 2.55 |
ENSMUST00000102580.3
|
2810408A11Rik
|
RIKEN cDNA 2810408A11 gene |
chr3_+_68869563 | 2.54 |
ENSMUST00000054551.2
|
1110032F04Rik
|
RIKEN cDNA 1110032F04 gene |
chr9_+_58014990 | 2.54 |
ENSMUST00000034874.7
|
Cyp11a1
|
cytochrome P450, family 11, subfamily a, polypeptide 1 |
chr13_-_37049203 | 2.53 |
ENSMUST00000037491.8
|
F13a1
|
coagulation factor XIII, A1 subunit |
chr7_-_139992544 | 2.51 |
ENSMUST00000026546.9
ENSMUST00000106069.2 ENSMUST00000148670.1 |
Adam8
|
a disintegrin and metallopeptidase domain 8 |
chr2_+_84840612 | 2.51 |
ENSMUST00000111625.1
|
Slc43a1
|
solute carrier family 43, member 1 |
chr5_+_90768511 | 2.50 |
ENSMUST00000031319.6
|
Ppbp
|
pro-platelet basic protein |
chr5_-_145584723 | 2.49 |
ENSMUST00000075837.6
|
Cyp3a41b
|
cytochrome P450, family 3, subfamily a, polypeptide 41B |
chr1_-_52953179 | 2.49 |
ENSMUST00000114492.1
|
1700019D03Rik
|
RIKEN cDNA 1700019D03 gene |
chr9_-_44288131 | 2.49 |
ENSMUST00000160384.1
|
Abcg4
|
ATP-binding cassette, sub-family G (WHITE), member 4 |
chr2_-_157007039 | 2.49 |
ENSMUST00000103129.2
ENSMUST00000103130.1 |
Dsn1
|
DSN1, MIND kinetochore complex component, homolog (S. cerevisiae) |
chr18_-_78142119 | 2.48 |
ENSMUST00000160639.1
|
Slc14a1
|
solute carrier family 14 (urea transporter), member 1 |
chr17_-_35702040 | 2.47 |
ENSMUST00000166980.2
ENSMUST00000145900.1 |
Ddr1
|
discoidin domain receptor family, member 1 |
chr1_+_135799402 | 2.47 |
ENSMUST00000152208.1
ENSMUST00000152075.1 ENSMUST00000154463.1 ENSMUST00000139986.1 |
Tnni1
|
troponin I, skeletal, slow 1 |
chr7_+_128062657 | 2.46 |
ENSMUST00000120355.1
ENSMUST00000106240.2 ENSMUST00000098015.3 |
Itgam
|
integrin alpha M |
chr6_-_136781718 | 2.45 |
ENSMUST00000078095.6
ENSMUST00000032338.7 |
Gucy2c
|
guanylate cyclase 2c |
chr11_+_120948480 | 2.45 |
ENSMUST00000070653.6
|
Slc16a3
|
solute carrier family 16 (monocarboxylic acid transporters), member 3 |
chr15_-_75111684 | 2.42 |
ENSMUST00000100542.3
|
Ly6c2
|
lymphocyte antigen 6 complex, locus C2 |
chr4_+_41569775 | 2.42 |
ENSMUST00000102963.3
|
Dnaic1
|
dynein, axonemal, intermediate chain 1 |
chr5_+_122100951 | 2.42 |
ENSMUST00000014080.6
ENSMUST00000111750.1 ENSMUST00000139213.1 ENSMUST00000111751.1 ENSMUST00000155612.1 |
Myl2
|
myosin, light polypeptide 2, regulatory, cardiac, slow |
chr1_-_119422239 | 2.42 |
ENSMUST00000038765.5
|
Inhbb
|
inhibin beta-B |
chr15_-_103255433 | 2.41 |
ENSMUST00000075192.6
|
Nfe2
|
nuclear factor, erythroid derived 2 |
chr5_-_113800356 | 2.41 |
ENSMUST00000160374.1
ENSMUST00000067853.5 |
Tmem119
|
transmembrane protein 119 |
chr17_-_35702297 | 2.41 |
ENSMUST00000135078.1
|
Ddr1
|
discoidin domain receptor family, member 1 |
chr2_-_32387760 | 2.40 |
ENSMUST00000050785.8
|
Lcn2
|
lipocalin 2 |
chr7_-_14123042 | 2.40 |
ENSMUST00000098809.2
|
Sult2a3
|
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 3 |
chr8_-_123859423 | 2.38 |
ENSMUST00000034452.5
|
Ccsap
|
centriole, cilia and spindle associated protein |
chr17_+_55952623 | 2.37 |
ENSMUST00000003274.6
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chr17_+_47726834 | 2.36 |
ENSMUST00000024782.5
ENSMUST00000144955.1 |
Pgc
|
progastricsin (pepsinogen C) |
chr4_+_121039385 | 2.35 |
ENSMUST00000030372.5
|
Col9a2
|
collagen, type IX, alpha 2 |
chr14_-_69284982 | 2.35 |
ENSMUST00000183882.1
ENSMUST00000037064.4 |
Slc25a37
|
solute carrier family 25, member 37 |
chr7_-_3677509 | 2.34 |
ENSMUST00000038743.8
|
Tmc4
|
transmembrane channel-like gene family 4 |
chr2_+_103969528 | 2.34 |
ENSMUST00000123437.1
ENSMUST00000163256.1 |
Lmo2
|
LIM domain only 2 |
chr9_+_51213683 | 2.31 |
ENSMUST00000034554.7
|
Pou2af1
|
POU domain, class 2, associating factor 1 |
chr11_-_94474088 | 2.30 |
ENSMUST00000107786.1
ENSMUST00000107791.1 ENSMUST00000103166.2 ENSMUST00000107792.1 ENSMUST00000100561.3 ENSMUST00000107793.1 ENSMUST00000107788.1 ENSMUST00000107790.1 ENSMUST00000107789.1 ENSMUST00000107785.1 ENSMUST00000021234.8 |
Cacna1g
|
calcium channel, voltage-dependent, T type, alpha 1G subunit |
chr3_-_54915867 | 2.29 |
ENSMUST00000070342.3
|
Sertm1
|
serine rich and transmembrane domain containing 1 |
chr17_+_31208049 | 2.28 |
ENSMUST00000173776.1
|
Ubash3a
|
ubiquitin associated and SH3 domain containing, A |
chr14_-_30915387 | 2.28 |
ENSMUST00000166622.1
|
Itih3
|
inter-alpha trypsin inhibitor, heavy chain 3 |
chr7_-_45920830 | 2.27 |
ENSMUST00000164119.1
|
Emp3
|
epithelial membrane protein 3 |
chr5_+_135023482 | 2.27 |
ENSMUST00000005509.4
|
Stx1a
|
syntaxin 1A (brain) |
chr13_+_73467197 | 2.26 |
ENSMUST00000022099.8
|
Lpcat1
|
lysophosphatidylcholine acyltransferase 1 |
chr11_-_98053415 | 2.26 |
ENSMUST00000017544.2
|
Stac2
|
SH3 and cysteine rich domain 2 |
chr2_-_165388245 | 2.26 |
ENSMUST00000103084.3
|
Zfp334
|
zinc finger protein 334 |
chr17_-_29237759 | 2.26 |
ENSMUST00000137727.1
ENSMUST00000024805.7 |
Cpne5
|
copine V |
chr12_-_114416895 | 2.26 |
ENSMUST00000179796.1
|
Ighv6-5
|
immunoglobulin heavy variable V6-5 |
chr6_-_128355826 | 2.25 |
ENSMUST00000001562.6
|
Tulp3
|
tubby-like protein 3 |
chr15_+_99074968 | 2.25 |
ENSMUST00000039665.6
|
Troap
|
trophinin associated protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.3 | 19.0 | GO:0002215 | defense response to nematode(GO:0002215) |
3.5 | 10.5 | GO:0030221 | basophil differentiation(GO:0030221) |
2.6 | 7.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
2.4 | 7.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.0 | 10.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.0 | 3.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
1.9 | 7.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.4 | 5.7 | GO:1902896 | terminal web assembly(GO:1902896) |
1.4 | 14.2 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 4.0 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
1.3 | 6.3 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
1.3 | 2.5 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
1.3 | 2.5 | GO:0051885 | positive regulation of anagen(GO:0051885) |
1.2 | 10.7 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
1.2 | 8.1 | GO:0015840 | urea transport(GO:0015840) |
1.2 | 3.5 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
1.1 | 3.4 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
1.1 | 3.3 | GO:0015811 | L-cystine transport(GO:0015811) |
1.1 | 4.4 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
1.1 | 4.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 8.7 | GO:0007144 | female meiosis I(GO:0007144) |
1.1 | 6.4 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
1.1 | 4.2 | GO:0060912 | cardiac cell fate specification(GO:0060912) |
1.0 | 4.1 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.0 | 6.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
1.0 | 3.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
1.0 | 3.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) |
1.0 | 4.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.0 | 3.8 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.9 | 15.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.9 | 0.9 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.9 | 7.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.9 | 4.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.9 | 2.6 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.8 | 5.9 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.8 | 2.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.8 | 1.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.8 | 4.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.8 | 0.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.7 | 2.2 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.7 | 2.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.7 | 10.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.7 | 3.6 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.7 | 4.3 | GO:0032796 | uropod organization(GO:0032796) |
0.7 | 7.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.7 | 6.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) cellular response to folic acid(GO:0071231) |
0.7 | 5.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.7 | 2.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.7 | 1.4 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.7 | 1.4 | GO:0060031 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.7 | 2.0 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.7 | 2.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.7 | 3.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.7 | 2.7 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of vascular wound healing(GO:0061043) |
0.7 | 3.9 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.6 | 10.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 2.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.6 | 1.9 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.6 | 2.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.6 | 1.9 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.6 | 2.5 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.6 | 2.4 | GO:0060279 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) positive regulation of ovulation(GO:0060279) |
0.6 | 3.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.6 | 23.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.6 | 3.0 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 3.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 1.8 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.6 | 4.1 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.6 | 1.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.6 | 1.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.6 | 6.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.6 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.5 | 2.2 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) |
0.5 | 1.1 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.5 | 0.5 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) |
0.5 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.5 | 1.6 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.5 | 2.1 | GO:0051944 | positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 1.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.5 | 2.6 | GO:0042891 | antibiotic transport(GO:0042891) |
0.5 | 3.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.5 | 3.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.5 | 2.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 3.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.5 | 4.5 | GO:0031179 | peptide modification(GO:0031179) |
0.5 | 1.5 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.5 | 2.0 | GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
0.5 | 2.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 1.5 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.5 | 1.5 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 4.4 | GO:0002432 | granuloma formation(GO:0002432) |
0.5 | 0.5 | GO:0035854 | eosinophil fate commitment(GO:0035854) |
0.5 | 4.8 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 1.0 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
0.5 | 2.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 1.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.5 | 4.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.5 | 1.9 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.5 | 1.9 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
0.5 | 1.4 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
0.5 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 2.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.5 | 1.8 | GO:0015825 | L-serine transport(GO:0015825) |
0.5 | 2.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.4 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.4 | 8.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.4 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 0.9 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 2.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.3 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.4 | 2.2 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.4 | 1.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 2.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 5.5 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.4 | 1.3 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 1.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 | 1.3 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.4 | 1.2 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 1.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 0.8 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.4 | 1.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.4 | 1.2 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 0.4 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.4 | 2.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.4 | 0.8 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.4 | 1.5 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
0.4 | 1.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.4 | 1.9 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.4 | 1.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 2.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 1.5 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.4 | 1.5 | GO:2000612 | regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.4 | 1.1 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.4 | 13.9 | GO:0048821 | erythrocyte development(GO:0048821) |
0.4 | 1.5 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.7 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 1.4 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.4 | 1.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.4 | 1.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.4 | 0.7 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.3 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 1.4 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.3 | 2.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.3 | 2.7 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.3 | 9.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 1.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 1.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 3.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 1.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 0.6 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 1.3 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.3 | 1.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.3 | 2.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 2.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.3 | 2.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 2.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.3 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.3 | 6.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.3 | 1.8 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.3 | 0.6 | GO:0036166 | phenotypic switching(GO:0036166) |
0.3 | 2.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 3.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 0.9 | GO:0061076 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.3 | 5.3 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 0.9 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.3 | 2.3 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.3 | 1.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.3 | 0.6 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.3 | 0.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.9 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.3 | 1.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.3 | 2.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.4 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.3 | 3.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 1.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 1.1 | GO:0045659 | negative regulation of neutrophil differentiation(GO:0045659) |
0.3 | 1.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.3 | 2.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.4 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.3 | 1.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.5 | GO:0035481 | Notch signaling pathway involved in heart induction(GO:0003137) regulation of Notch signaling pathway involved in heart induction(GO:0035480) positive regulation of Notch signaling pathway involved in heart induction(GO:0035481) |
0.3 | 1.3 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 0.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.3 | 0.8 | GO:0030824 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
0.3 | 1.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.3 | 0.5 | GO:0015675 | nickel cation transport(GO:0015675) |
0.3 | 0.5 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.3 | 3.6 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.3 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 2.5 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.3 | 1.8 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 1.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 1.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.3 | 2.8 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 0.7 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 1.0 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.2 | 1.9 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
0.2 | 0.2 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.2 | 1.2 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.7 | GO:0019043 | establishment of viral latency(GO:0019043) |
0.2 | 0.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.2 | 0.7 | GO:2000387 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) positive regulation of ovarian follicle development(GO:2000386) regulation of antral ovarian follicle growth(GO:2000387) positive regulation of antral ovarian follicle growth(GO:2000388) |
0.2 | 0.9 | GO:0060032 | notochord regression(GO:0060032) |
0.2 | 1.4 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 0.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.2 | 0.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.2 | 5.3 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.2 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 1.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.2 | 1.1 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 2.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 3.7 | GO:0033574 | response to testosterone(GO:0033574) |
0.2 | 0.4 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.2 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.2 | 0.9 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.2 | 0.9 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
0.2 | 0.6 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.2 | 0.9 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.2 | 1.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.2 | 1.7 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 3.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.2 | 0.4 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 3.1 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.2 | 0.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.8 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 1.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.2 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.4 | GO:0002554 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
0.2 | 0.8 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 1.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 1.0 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.2 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.2 | 0.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.6 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.2 | 2.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.2 | 1.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 1.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.2 | 0.8 | GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902167) |
0.2 | 2.0 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 0.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 0.6 | GO:2000389 | neutrophil extravasation(GO:0072672) regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.2 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.2 | 1.0 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 2.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.8 | GO:0033368 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.2 | 1.0 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.2 | 6.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.2 | 2.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 0.4 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.2 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.2 | 0.7 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
0.2 | 1.9 | GO:0015810 | aspartate transport(GO:0015810) |
0.2 | 1.3 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:1990773 | regulation of matrix metallopeptidase secretion(GO:1904464) matrix metallopeptidase secretion(GO:1990773) |
0.2 | 0.9 | GO:0032901 | regulation of neurotrophin production(GO:0032899) positive regulation of neurotrophin production(GO:0032901) |
0.2 | 1.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 1.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 1.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.4 | GO:2000554 | regulation of T-helper 1 cell cytokine production(GO:2000554) positive regulation of T-helper 1 cell cytokine production(GO:2000556) |
0.2 | 0.5 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.2 | 2.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.2 | 1.6 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 2.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 1.0 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 1.2 | GO:0035799 | ureter maturation(GO:0035799) |
0.2 | 1.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.2 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 1.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.7 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.2 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.9 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.0 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.8 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 2.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.2 | 3.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.2 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) GTP biosynthetic process(GO:0006183) |
0.2 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 0.3 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.2 | 0.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.2 | 0.5 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 3.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 3.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 1.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.2 | 3.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.2 | 1.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.2 | 1.4 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 1.3 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.2 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.4 | GO:0032261 | purine nucleotide salvage(GO:0032261) IMP salvage(GO:0032264) |
0.2 | 0.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.2 | 0.3 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.2 | 0.8 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 1.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 3.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.2 | 0.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 0.9 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.2 | 1.1 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 2.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.6 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.4 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.1 | 0.4 | GO:2000321 | negative regulation of interleukin-1 beta secretion(GO:0050713) positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 1.0 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 1.6 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.7 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 1.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.5 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 0.9 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.1 | 6.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.1 | 0.3 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
0.1 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 1.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 1.7 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.1 | 0.3 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.1 | 1.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 4.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.6 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 3.6 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.1 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.1 | 3.6 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.3 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.1 | 0.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 2.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 1.2 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.4 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.1 | 0.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.5 | GO:0035989 | tendon development(GO:0035989) |
0.1 | 4.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.1 | 0.4 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.7 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.4 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.2 | GO:0036371 | T-tubule organization(GO:0033292) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 1.4 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.8 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.1 | 2.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 7.4 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 1.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.1 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 1.0 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.4 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.1 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.5 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.9 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.9 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.1 | 9.9 | GO:0030168 | platelet activation(GO:0030168) |
0.1 | 2.4 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 2.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.1 | 2.6 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 10.1 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.1 | 0.6 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
0.1 | 0.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.5 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 1.4 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 1.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) |
0.1 | 1.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
0.1 | 1.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.6 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.8 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.2 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 1.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.8 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.1 | 0.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.2 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.6 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.4 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 2.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.1 | 0.3 | GO:0071351 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.1 | 0.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.1 | 0.5 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.7 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 1.7 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 1.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:1900212 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.1 | 2.5 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.4 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.1 | 0.3 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.2 | GO:1904579 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.1 | 0.5 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 1.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 5.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.8 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 5.3 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.1 | 0.1 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.3 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 1.3 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.8 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 0.5 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.9 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.4 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.1 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 1.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 2.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.5 | GO:0030194 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.3 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.1 | 0.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
0.1 | 0.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.3 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.3 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.8 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.7 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 3.5 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 1.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.1 | 0.7 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.9 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 2.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.3 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.2 | GO:1990918 | double-strand break repair involved in meiotic recombination(GO:1990918) |
0.1 | 0.9 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 1.5 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.8 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.7 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 1.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.7 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.5 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.2 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 0.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.7 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.1 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.1 | 0.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.1 | 0.6 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.1 | 0.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.3 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 1.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 0.9 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 1.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 1.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 1.4 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.4 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) lung secretory cell differentiation(GO:0061140) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 1.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.2 | GO:0042697 | menopause(GO:0042697) |
0.1 | 0.6 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.1 | 0.2 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.1 | 0.1 | GO:0061193 | stem cell fate commitment(GO:0048865) taste bud development(GO:0061193) |
0.1 | 0.2 | GO:0086064 | AV node cell to bundle of His cell communication by electrical coupl |